EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer

Jiachen Xu, Rui Wan, Yiran Cai, Shangli Cai, Lin Wu, Baolan Li, Jianchun Duan, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu und 48 weitere

Cancer Cell · 2024

DOI: 10.1016/j.ccell.2024.08.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024. Verfasst von Jiachen Xu und 59 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Ca…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Circulating Tumor DNA, Lung Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Nova Program, Chinese Academy of Meteorological Sciences, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungCirculating Tumor DNALung NeoplasmsImmune Checkpoint InhibitorsHumansBiomarkers, TumorAntineoplastic Combined Chemotherapy ProtocolsFemaleMaleMiddle AgedProgrammed Cell Death 1 ReceptorAgedMutationHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

PD-1 inhibitorblood-based genomic immune subtypechemotherapycirculating tumor DNAnon-small-cell lung cancerpersonalized medicinestratification strategy

Substanzen

Circulating Tumor DNAImmune Checkpoint InhibitorsBiomarkers, TumorProgrammed Cell Death 1 ReceptorPDCD1 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospit…
  • Burning Rock Biotech, Guangzhou, China.
  • Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Jilin Cancer Hospital, Changchun, China.
  • Liaoning Cancer Hospital & Institute, Shenyang, China.

Förderung

  • Beijing Nova Program
  • Chinese Academy of Meteorological Sciences
  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Xu, J., Wan, R., Cai, Y., Cai, S., Wu, L., Li, B., Duan, J., Cheng, Y., Li, X., Wang, X., Han, L., Wu, X., Fan, Y., Yu, Y., Lv, D., Shi, J., Huang, J., Zhou, S., Han, B., …, & Feng, J. (2024). Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.08.013

Vancouver

Xu J, Wan R, Cai Y, Cai S, Wu L, Li B, et al. Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer. Cancer Cell. 2024. doi:10.1016/j.ccell.2024.08.013

BibTeX
@article{Xu2024,
  author = {Xu, Jiachen and Wan, Rui and Cai, Yiran and Cai, Shangli and Wu, Lin and Li, Baolan and Duan, Jianchun and Cheng, Ying and Li, Xiaoling and Wang, Xicheng and Han, Liang and Wu, Xiaohong and Fan, Yun and Yu, Yan and Lv, Dongqing and Shi, Jianhua and Huang, Jianjin and Zhou, Shaozhang and Han, Baohui and Sun, Guogui and Guo, Qisen and Ji, Youxin and Zhu, Xiaoli and Hu, Sheng and Zhang, Wei and Wang, Qiming and Jia, Yuming and Wang, Ziping and Song, Yong and Wu, Jingxun and Shi, Meiqi and Li, Xingya and Han, Zhigang and Liu, Yunpeng and Yu, Zhuang and Liu, An-Wen and Wang, Xiuwen and Zhou, Caicun and Zhong, Diansheng and Miao, Liyun and Zhang, Zhihong and Zhao, Hui and Yang, Jun and Wang, Dong and Wang, Yingyi and Li, Qiang and Zhang, Xiaodong and Ji, Mei and Yang, Zhenzhou and Cui, Jiuwei and Gao, Beili and Wang, Buhai and Liu, Hu and Nie, Lei and He, Mei and Jin, Shi and Gu, Wei and Shu, Yongqian and Zhou, Tong and Feng, Jian},
  title = {Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer},
  journal = {Cancer Cell},
  year = {2024},
  doi = {10.1016/j.ccell.2024.08.013}
}
Kostenlos starten →